Position in JNJ
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$143,960
-$15,659,574 QoQ
Shares Held
46,182
-28.6% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#4,537
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026GFS Advisors, LLC holds $987,567 across 10 Drug Manufacturers - General names. JNJ ranks #3 (14.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
300 | $359,829 | |
| 2 | NVO |
Novo Nordisk A S
|
5,840 | $279,969 | |
| 3 | JNJ |
Johnson & Johnson
This page
|
46,182 | $143,960 | |
| 4 | ABBV |
AbbVie Inc.
|
10,263 | $143,938 | |
| 5 | GSK |
GSK plc
|
372 | $19,500 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
26,710 | $18,634 | |
| 7 | OGN |
Organon & Co.
|
1,267 | $17,155 | |
| 8 | MRK |
Merck & Co., Inc.
|
79,011 | $3,361 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $143,960 | 46,182 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $15,803,534 | 64,652 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $10,299,280 | 49,767 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $9,919,228 | 53,496 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $8,147,379 | 53,338 | Shares | Sole | 2025-07-25 | |
| 2025-03-31 | $8,514,059 | 51,339 | Shares | Sole | 2025-04-21 | |
| 2024-12-31 | $7,547,717 | 52,190 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $8,236,375 | 50,823 | Shares | Sole | 2024-10-29 | |
| 2024-06-30 | $22,070 | 151 | Shares | Sole | 2024-07-26 | |
| 2024-03-31 | $7,522,409 | 47,553 | Shares | Sole | 2024-04-25 | |
| 2023-12-31 | $7,418,504 | 47,330 | Shares | Sole | 2024-01-24 | |
| 2023-09-30 | $6,790,700 | 43,600 | Shares | Sole | 2023-10-19 | |
| 2023-06-30 | $4,331,492 | 26,169 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $4,018,995 | 25,929 | Shares | Sole | 2023-04-27 | |
| 2022-12-31 | $4,349,652 | 24,623 | Shares | Sole | 2023-01-26 | |
| 2022-09-30 | $4,004,443 | 24,513 | Shares | Sole | 2022-10-13 | |
| 2022-06-30 | $4,427,631 | 24,943 | Shares | Sole | 2022-07-19 | |
| 2022-03-31 | $4,951,274 | 27,937 | Shares | Sole | 2022-04-21 | |
| 2021-12-31 | $7,995,298 | 46,737 | Shares | Sole | 2022-01-21 | |
| 2021-09-30 | $1,601,595 | 9,917 | Shares | Sole | 2021-11-03 | |
| 2021-06-30 | $1,789,405 | 10,862 | Shares | Sole | 2021-07-26 | |
| 2021-03-31 | $1,744,082 | 10,612 | Shares | Sole | 2021-05-03 | |
| 2020-12-31 | $1,383,684 | 8,792 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $1,308,952 | 8,792 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $1,236,418 | 8,792 | Shares | Sole | 2020-07-29 | |
| 2020-03-31 | $1,205,346 | 9,192 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||